Biohaven Ltd (NYSE:BHVN) finished Friday with a subtraction of $0.0 to close at $26.01, a downside of 0.00 percent. An average of 2,652,620 shares of common stock have been traded in the last five days. There was a gain of $9.08 in the past week, and it reached a new high 26 times over the past 12 months. The last 20 days have seen an average of 1,276,555 shares traded, while the 50-day average volume stands at 1,081,608.
BHVN stock has increased by 41.21% in the last month. The company shares reached their 1-month lowest point of $16.45 on 09/21/23. With the stock rallying to its 52-week high on 09/29/23, shares of the company touched a low of $5.54 and a high of $26.64 in 52 weeks. It has reached a new high 20 times so far this year and achieved 87.39% or $12.13 in price. In spite of this, the price is down -2.36% from the 52-week high.
Valuation Metrics
Biohaven Ltd (BHVN) stock’s beta is 5.27. Other valuation ratios to consider include the price-to-book (PB) ratio at 4.59.
Financial Health
The quick ratio of Biohaven Ltd for the three months ended June 29 was 4.94, and the current ratio was 4.94, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.08 and a total debt to equity ratio of 0.08 for the quarter ending June 29.
Earnings Surprise
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$90.35 million in the quarter, while revenues were shrunk -388.53%. The analyst consensus anticipated Biohaven Ltd’s latest quarter earnings to come in at -$1.21 per share, but it turned out to be -$1.32, a -9.10% surprise. For the quarter, EBITDA amounted to -$92.18 million. Shareholders own equity worth $68.32 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Biohaven Ltd (BHVN) price momentum. RSI 9-day as of the close on 29 September was 83.12%, suggesting the stock is Overbought, with historical volatility in this time frame at 149.52%.
As of today, BHVN’s price is $22.09 +53.63% or $9.08 from its 5-day moving average. BHVN is currently trading +42.21% higher than its 20-day SMA and +83.04% higher than its 100-day SMA. However, the stock’s current price level is +5.09% above the SMA50 and +60.16% above the SMA200.
The stochastic %K and %D were 88.29% and 68.00%, respectively, and the average true range (ATR) was 1.81. With the 14-day stochastic at 87.31% and the average true range at 1.57, the RSI (14) stands at 75.41%. The stock has reached 5.22 on the 9-day MACD Oscillator while the 14-day reading was at 5.56.
Analyst Ratings
SVB Securities launched coverage on Biohaven Ltd (NYSE: BHVN) in its analyst report released on January 24, 2023. The firm assigned the stock an Outperform rating.
What is BHVN’s price target for the next 12 months?
Analysts predict a range of price targets between $23.00 and $31.00, with a median target of $27.00. Taking a look at these predictions, the average price target given by analysts for Biohaven Ltd (BHVN) stock is $27.00.
